Form D · Biotechnology
DMC Biotechnologies, Inc.
Boulder, CO · CIK 0001728411
Offering snapshot reported Dec 30, 2025 · SEC filing
- Reported sold
- $1.41M Offering amount: $2.5M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 16, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 30, 2025 | Initial | $1,414,267 | No comparison | 7 | SEC filing |
| Dec 30, 2025 | Initial | $904,500 | No comparison | 4 | SEC filing |
| Apr 23, 2025 | Initial | $4,791,203 | No comparison | 9 | SEC filing |
| Aug 24, 2022 | Initial | $66,720 | No comparison | 1 | SEC filing |
| Dec 10, 2021 | Initial | $33,760,493 | No comparison | 12 | SEC filing |
| Jan 28, 2021 | Initial | $22,446 | No comparison | 1 | SEC filing |
| Jun 27, 2019 | Initial | $4,649,995 | No comparison | 3 | SEC filing |
| Mar 15, 2019 | Amendment | $2,537,660 | $1,370,994vs Jan 18, 2018 | 3 | SEC filing |
| Jan 18, 2018 | Initial | $1,166,666 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-568461
Promissory notes convertible into equity securities of the Issuer and the equity securities to be issued upon such conversion
Source: Form D, filed Dec 30, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Josko Bobanovic | Director |
| Doug Cameron | Director |
| Alastair Cooper | Director |
| Jim Flatt | Director, Executive |
| Carolyn Fritz | Director |
| Ashley Jenkins | Executive |
| K'lynne Johnson | Director |
| Matthew Lipscomb | Director |
| Michael D. Lynch | Director |
| Rob Van Der Meij | Director |
| Josh Yelen | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2477 55 Th Street, Suite 120
Boulder, CO, 80301
Boulder, CO, 80301